Annual Short Term Debt
$0.00
-$1.92 M-100.00%
31 December 2023
Summary:
Cara Therapeutics annual short term debt is currently $0.00, with the most recent change of -$1.92 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$1.60 million (-100.00%). CARA annual short term debt is now -100.00% below its all-time high of $1.92 million, reached on 31 December 2022.CARA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$3.42 M
+$3.25 M+1933.93%
30 September 2024
Summary:
Cara Therapeutics quarterly short term debt is currently $3.42 million, with the most recent change of +$3.25 million (+1933.93%) on 30 September 2024. Over the past year, it has increased by +$2.92 million (+587.53%). CARA quarterly short term debt is now at all-time high.CARA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +587.5% |
| 3 y3 years | -100.0% | +99.1% |
| 5 y5 years | 0.0% | +261.6% |
CARA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at high | ||
| 5 y | 5 years | -100.0% | at high | ||
| alltime | all time | -100.0% | at high |
Cara Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.42 M(+1933.9%) |
| June 2024 | - | $168.00 K(-23.6%) |
| Mar 2024 | - | $220.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2023 | - | $497.00 K(-49.4%) |
| June 2023 | - | $982.00 K(-32.6%) |
| Mar 2023 | - | $1.46 M(-24.1%) |
| Dec 2022 | $1.92 M(+9.3%) | $1.92 M(+2.2%) |
| Sept 2022 | - | $1.88 M(+2.2%) |
| June 2022 | - | $1.83 M(+2.2%) |
| Mar 2022 | - | $1.79 M(+2.3%) |
| Dec 2021 | $1.75 M | $1.75 M(+2.3%) |
| Sept 2021 | - | $1.72 M(+2.3%) |
| June 2021 | - | $1.68 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $1.64 M(+2.3%) |
| Dec 2020 | $1.60 M(+65.7%) | $1.60 M(+55.5%) |
| Sept 2020 | - | $1.03 M(+2.4%) |
| June 2020 | - | $1.01 M(+1.5%) |
| Mar 2020 | - | $991.00 K(+2.5%) |
| Dec 2019 | $967.00 K(>+9900.0%) | $967.00 K(+2.3%) |
| Sept 2019 | - | $945.00 K(+2.4%) |
| June 2019 | - | $923.00 K(+2.4%) |
| Mar 2019 | - | $901.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $998.00 K(-19.0%) |
| June 2016 | - | $1.23 M(+296.1%) |
| Sept 2013 | - | $311.00 K(-60.1%) |
| Dec 2012 | $780.00 K(+3.6%) | $780.00 K |
| Dec 2011 | $753.00 K | - |
FAQ
- What is Cara Therapeutics annual short term debt?
- What is the all time high annual short term debt for Cara Therapeutics?
- What is Cara Therapeutics annual short term debt year-on-year change?
- What is Cara Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Cara Therapeutics?
- What is Cara Therapeutics quarterly short term debt year-on-year change?
What is Cara Therapeutics annual short term debt?
The current annual short term debt of CARA is $0.00
What is the all time high annual short term debt for Cara Therapeutics?
Cara Therapeutics all-time high annual short term debt is $1.92 M
What is Cara Therapeutics annual short term debt year-on-year change?
Over the past year, CARA annual short term debt has changed by -$1.92 M (-100.00%)
What is Cara Therapeutics quarterly short term debt?
The current quarterly short term debt of CARA is $3.42 M
What is the all time high quarterly short term debt for Cara Therapeutics?
Cara Therapeutics all-time high quarterly short term debt is $3.42 M
What is Cara Therapeutics quarterly short term debt year-on-year change?
Over the past year, CARA quarterly short term debt has changed by +$2.92 M (+587.53%)